- Detailed programme and speakers
- Abstract submission
- Price & registration
- Back to the congress Homepage
- Venue, Transport, Accomodation
Your support is vital and will play a key role in making this conference a success, allowing us to continue contributing to the advancement of pharmaceutical sciences.
Exhibition
Suppliers will have the opportunity to showcase their latest technologies at the upcoming event. Enging with current and potential customers through a live exhibition is an excellent way to connect. Reserved spaces in the posters and coffee/lunch breaks area will be allocated for “table top”, ensuring great visibility for participants. Additionaly, various sponsorship opportunities are available.
Sponsoring
All sponsoring options include:
- your logo and company description (5 lines) placed in the conference booklet and on our congress website
- company logo in the congress newsletter
| Prices | PRICE IN € VAT EXCLUDED |
|---|---|
| Exhibit, participate and sponsor – A: 1 conference registration 1 table top and 2 chairs 1 full page advert in the conference book, | 3 000 |
| Participate and sponsor – B: 2 conference registrations 1 full page advert in the conference book, | 2 500 |
| Participate and sponsor – C: 1 conference registration, 1 full page advert in the conference book | 1 800 |
| Sponsor coffee break (available 4 times) – It will be provided by the organizer with no additional cost for the sponsor | 1 200 |
| Advertising in the conference book: full color page | 800 |
| Basic sponsoring: company name and logo, description (5 lines) in the conference book | 500 |
For special request, please contact Laurence Houzé: apgi@apgi.org
The level of sponsor status depends on your financial support
- Bronze sponsorship starting from 500 €
- Silver sponsorship starting from 1000 €
- Gold sponsorship starting from 2500 €
Our sponsors
Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectables across a wide range of therapeutic areas. Our innovative treatments aim to ensure adherence to medical prescriptions, improve drug efficacy and accessibility, and reduce environmental impact. They combine active pharmaceutical ingredients with our proprietary BEPO® technology, which enables controlled drug release at therapeutic levels over several days, weeks or months from a subcutaneous or local injection of a fully bioresorbable depot just a few millimeters in size.
The first treatment based on BEPO® technology, developed for the treatment of schizophrenia, was approved by the FDA in April 2023 and is now marketed in the United States by Teva Pharmaceuticals under the name UZEDY®. We collaborate with leading pharmaceutical companies and foundations to advance global health through new treatment options.
Headquartered in Montpellier, Medincell currently employs over 140 people representing more than 25 different nationalities.
Our exhibitors
KORSCH is a global leader in tableting technology, offering innovative, tailor-made solutions from early R&D to full-scale production, ensuring that each client’s unique needs are met with precision and expertise.
By leveraging our extensive experience in the tableting industry and our deep understanding of production processes, formulators’ needs and technology, MEDELPHARM keeps creating new generations of STYL’One Compaction Simulators to expand possibilities for scientists, offering them solutions to speed up their tableting development. With extensive knowledge gathered by scientists from our INNOVATION CENTERs and Science Lab, we provide support from formulation development to process optimization for all applications.”
MeltPrep enables rapid, lossless formulation screening of novel dosage forms.
Our VCM technology molds homogeneous samples directly from powders, ideal for early-stage development. Free-D Molding supports fast prototyping of custom geometries, while the MeltPrep Slider delivers rapid thermal analysis with minimal material use.
Streamline your formulation work: smarter, faster, with fewer steps and less waste.
Our technologies deliver critical insights into particle size, shape, concentration, and zeta potential, as well as biomolecular stability and interactions—supporting the design and optimization of next-generation therapeutics and delivery systems.
